Evidence map›Paper›PMID 38882363›Full record

ArticleHeliyon2024

CXC chemokine receptor type 5 may induce trophoblast dysfunction and participate in the processes of unexplained missed abortion, wherein

Yanan Zhi, Pingping Zhang, Yan Luo, Yanmei Sun, Juan Li, Mingming Zhang, Yali Li

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanan ZhiDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Pingping ZhangDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Yan LuoDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Yanmei SunDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Juan LiDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Mingming ZhangHebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang, Hebei, PR China.
Yali LiDepartment of Reproductive and Genetics, Hebei General Hospital, Shijiazhuang, Hebei, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokines regulate the trophoblast dysfunction involved in the occurrence and development of pathological pregnancy, including missed abortions. In particular, CXC chemokine receptor type 5 mediates cell proliferation, migration, and inflammation; nonetheless, its role in missed abortions remains unclear. This study aimed to examine the expression of CXC chemokine receptor type 5 in missed abortions and to investigate the effects of CXC chemokine receptor type 5 on the biological behaviour of trophoblasts, as well as the underlying mechanisms. Our results indicated that CXC chemokine receptor type 5 was upregulated in the villi of women who experienced unexplained missed abortions, as compared with those who had normal pregnancies. CXC chemokine receptor type 5 inhibited the proliferation and migration of human first-trimester trophoblast/simian virus cells but promoted cell apoptosis. With respect to its mechanisms, CXC chemokine receptor type 5 activated the extracellular signal-regulated protein kinase 1/2 signalling pathway and upregulated the secretion of interleukin-6; however, it had no effect on the secretion of tumour necrosis factor-α. In conclusion, our findings suggest that CXC chemokine receptor type 5 induces trophoblast dysfunction and participates in the processes of unexplained missed abortions, wherein

Indexed as

CXC chemokine receptor type 5Extracellular signal-regulated protein kinase signal pathwayInterleukin-6Missed abortionTrophoblastTumour necrosis factor-α

Identifiers

PMID38882363
PMCPMC11176800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.